Growth forecast for drug delivery systems market

7 May 2020
vials_dugs_biologic_report_test_big

COVID-19 is having varying effects on different markets within healthcare, with drug delivery systems one of those areas that could be given a boost by the pandemic’s impact, according to Fact. MR.

The intelligence provider predicts compound annual growth rate (CAGR) of 7% between 2020 and 2025, against a background of rising infections that is leading healthcare providers to grapple with rising shortfalls in the provision of essential medical equipment such as respirators and ventilators.

Nanotechnology and localized drug delivery key to growth

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Biotechnology